Education
About Us
Working with TipRanks
Follow Us
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
Rec-1245
Locally Advanced, Unresectable, Metastatic Cancers, Relapsed/Refractory Lymphomas
Phase I/II
Recruiting
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Oct 29, 2024
―
Rec-3964
Recurrent Clostridioides Difficile Infection
Phase II
Terminated
The Clostridioides Difficile Trial of REC-3964
Jul 15, 2024
―
Rec-4881
Solid Tumor, Axin1 Gene Mutation, Apc Gene Mutation
Phase II
Active Not Recruiting
A Study of REC-4881 in Participants with Cancers Which Have an AXIN1 or APC Mutation
Aug 10, 2023
―
Rec-4881
Familial Adenomatous Polyposis
Phase I/II
Recruiting
Evaluate REC-4881 in Patients With FAP
Sep 14, 2022
―
Rec-2282
Neurofibromatosis Type 2
Phase II/III
Terminated
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas
Nov 10, 2021
―
Rec-994
Cerebral Cavernous Malformation
Phase II
Completed
The Symptomatic Cerebral Cavernous Malformation Trial of REC-994
Oct 08, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Recursion Pharmaceuticals (RXRX) have in its pipeline
RXRX is currently developing the following drugs: Rec-1245, Rec-3964, Rec-4881. These drug candidates are in various stages of clinical development as the company works toward FDA approval.